| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/15/2008 | US7358098 Device for capturing beads and method and apparatus for arraying beads |
| 04/15/2008 | US7358097 Making a matrix of random encoded arrays |
| 04/15/2008 | US7358096 Immobilisation of proteins |
| 04/15/2008 | US7358095 Diameter of transparent, flexible tube increases with centrifugal force, permits density-based axial movement of blood; optical analysis; reduced centrifugation speed decreases tube failure, less contamination |
| 04/15/2008 | US7358094 Bioassay comprising saccharide sensing beads for use in determining blood glucose concentration |
| 04/15/2008 | US7358093 Aztreonam L-lysine and methods for the preparation and analysis thereof |
| 04/15/2008 | US7358092 Method for the determination of 25-hydroxycholecalciferol in feed |
| 04/15/2008 | US7358091 Perfusing blood through channel coated with collagen; measure thrombosis and arachidonic acid/shear-induced platelet aggregation; citrate, phenylalanine-proline-arginine-chloromethylketone and heparin; clopidogrel bisulfate, ticlopidine HCI; preventing cardiovascular disorders |
| 04/15/2008 | US7358088 And GD domains by determining if agent inhibits or augments heterodimerization of polypeptides; use in diagnosis of degenerative disorders (inflammatory conditions, cancer) |
| 04/15/2008 | US7358086 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/15/2008 | US7358081 Preferred nucleotide sequences are detected in the solution by working electrodes which have been coated with special biopolymers, only the exactly matching nucleotide sequences settle on the working electrode inserted in to the fluid |
| 04/15/2008 | US7358079 Flow cell array and the utilization thereof for multianalyte determination |
| 04/15/2008 | US7358078 Auto microfluidic hybridization chip platform |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358066 Variants and exons of the GlyT1 transporter |
| 04/15/2008 | US7358064 Fluorescent or luminescent potentiometric probes |
| 04/15/2008 | US7358063 Method of detecting PS2V |
| 04/15/2008 | US7358062 Assaying for pepsinogen, gastrin, and Helicobacter pylori concentration; kits |
| 04/15/2008 | US7358061 Methods of diagnosing thyroid carcinoma |
| 04/15/2008 | US7358060 Method for monitoring and prognosis of disease course of gastrointestinal tumors |
| 04/15/2008 | US7358059 Simultaneous quantification of PIG-A associated proteins in red cells, platelets and leukocyte subsets using a single measurement |
| 04/15/2008 | US7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease |
| 04/15/2008 | US7358057 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/15/2008 | US7358056 Methods for modulating signal transduction mediated by TGF-β and related proteins |
| 04/15/2008 | US7358055 Diagnostic markers of acute coronary syndrome and methods of use thereof |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | US7358053 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 04/15/2008 | US7358052 Detection of preferential particles in sample; obtain sample, incubate with binding agent, expose to electric field and probes, detect signal |
| 04/15/2008 | US7358046 Sensitivity test to predict efficacy of anti-cancer therapies |
| 04/15/2008 | US7358045 Using engrailed-2 (En-2) gene expression as a diagnostic and prognostic indicator of mammary gland cell proliferative disorders; antisense agents |
| 04/15/2008 | US7358043 Generation of gene expression map; obtain sample cells, generate expression pattern for preferential genes, monitor activities associated with pattern and compare to control, evaluate for genetic defect |
| 04/15/2008 | US7358042 Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 04/15/2008 | US7358041 Antibodies to magmas and uses thereof |
| 04/15/2008 | US7358040 MRE 11: modulation of cellular proliferation |
| 04/15/2008 | US7357928 Proteins for treatment of cancer by administering antinucleolin |
| 04/15/2008 | US7357916 Method for creating a uniform vascular wound in zebrafish or zebrafish larva |
| 04/15/2008 | US7357915 Method of imaging cell death in vivo |
| 04/15/2008 | US7357913 Methods for detecting, prognosing, or monitoring a disorder by comparing relative flux rates of two or more biological molecules in vivo |
| 04/15/2008 | US7357906 Method for fractionating single-wall carbon nanotubes |
| 04/15/2008 | US7357896 Resistometer |
| 04/15/2008 | US7357323 Obtaining product item assistance |
| 04/15/2008 | US7357046 Method for dissolution testing of a pharmaceutical delivery device |
| 04/15/2008 | US7357016 Process and device for determining viscosity |
| 04/15/2008 | US7357015 Gas concentration sensor, hydrogen purification unit using this and fuel cell system |
| 04/15/2008 | CA2452493C Fluorescence polarization-based homogeneous assay for aflatoxins |
| 04/15/2008 | CA2409602C Biosensor and deposit sensor for monitoring biofilm and other deposits |
| 04/15/2008 | CA2321279C Fiber sampling device |
| 04/15/2008 | CA2313164C Skin test for schizophrenia |
| 04/15/2008 | CA2264277C Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
| 04/13/2008 | CA2566565A1 Method and apparatus for evaluating contamination measurements |
| 04/12/2008 | CA2579184A1 Augmenting stem cell populations by modulating t-cell protein tyrosine phosphatase (tc-ptp) |
| 04/10/2008 | WO2008043104A2 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 04/10/2008 | WO2008042826A2 Use of omentin 1 and omentin 2 in the diagnosis and treatment of disease |
| 04/10/2008 | WO2008042806A2 Stilbenedisulfonic acid derivatives as inhibitors of retroviral integrase |
| 04/10/2008 | WO2008042508A1 Grp78 as a predictor of responsiveness to therapeutic agents |
| 04/10/2008 | WO2008042481A2 A method for the detection and neutralization of bacteria |
| 04/10/2008 | WO2008042469A2 Knockout mice for different genes and their use for gene characterizatio |
| 04/10/2008 | WO2008042436A2 Biomarkers and assays for the treatment of cancer |
| 04/10/2008 | WO2008042190A2 Detection of neurodegenerative disease |
| 04/10/2008 | WO2008042156A1 Maximizing oligonucleotide loading on gold nanoparticle |
| 04/10/2008 | WO2008042027A1 System and method for limiting sensor exposure to ozone |
| 04/10/2008 | WO2008042024A2 Neuroactive fragments of app |
| 04/10/2008 | WO2008042012A1 Compositions and methods for detecting and treating renal injury and inflammation |
| 04/10/2008 | WO2008042006A1 System and method for providing telediagnostic services |
| 04/10/2008 | WO2008042001A1 High throughput screening methods for anti-metastatic compounds |
| 04/10/2008 | WO2008041953A2 Dengue diagnosis and treatment |
| 04/10/2008 | WO2008041944A1 Device for drug screening |
| 04/10/2008 | WO2008041930A1 Molecular assembly on a substrate |
| 04/10/2008 | WO2008041849A2 Methods and means for determining satiety on saliva |
| 04/10/2008 | WO2008041773A1 Analysis kit, analyzer and analysis method |
| 04/10/2008 | WO2008041767A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 04/10/2008 | WO2008041594A1 Method for testing on sensitivity to antibody drug |
| 04/10/2008 | WO2008041220A1 A method of generating a platelet reactivity profile for an individual |
| 04/10/2008 | WO2008041217A1 Centrosome amplification as a biosensor for dna damage |
| 04/10/2008 | WO2008041124A1 A method and device for quality inspection of vegetable produce |
| 04/10/2008 | WO2008041004A2 Preparation method |
| 04/10/2008 | WO2008040998A2 Systems and methods for determining a substantially hematocrit independent analyte concentration |
| 04/10/2008 | WO2008040994A2 Fluoro-substituted benzoxazole polymethine dyes |
| 04/10/2008 | WO2008040990A2 Methods for determining an analyte concentration using signal processing algorithms |
| 04/10/2008 | WO2008040983A1 Assay device |
| 04/10/2008 | WO2008040982A1 Method for determining hematocrit corrected analyte concentrations |
| 04/10/2008 | WO2008040975A1 Sensors and substances for detecting particles in air |
| 04/10/2008 | WO2008040883A1 Use of the 7f4 protein in the in vitro diagnosis of mycoplasma pneumoniae infections |
| 04/10/2008 | WO2008040882A2 Method of diagnosing neuropsychiatric diseases, eating disorders or metabolic diseases |
| 04/10/2008 | WO2008040779A1 Thermophilic sulfate-binding protein, its use and a biosensor comprising the protein |
| 04/10/2008 | WO2008040704A1 Device for a textile machine for measuring the length-specific mass and/or the moisture of a strand-shaped, continuous fiber batch, and textile machine |
| 04/10/2008 | WO2008040532A1 Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells |
| 04/10/2008 | WO2008040395A1 Method for detachably connecting a sensor for fluid analysis to a body containing said fluid, and corresponding apparatus |
| 04/10/2008 | WO2008040386A1 Method for on-site drug detection in illicit drug samples |
| 04/10/2008 | WO2008040362A2 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 04/10/2008 | WO2008040348A2 High througput methods for characterization of antibodies |
| 04/10/2008 | WO2008040328A2 Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure |
| 04/10/2008 | WO2008040144A1 Blood smear substrate and blood smear device |
| 04/10/2008 | WO2008040116A1 Methods of detecting and monitoring cancer using 3d analysis of centromeres |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008040059A1 Anti-bacterially active agents and related methods |
| 04/10/2008 | WO2008040045A1 General prognostic parameters for tumour patients |
| 04/10/2008 | WO2008040044A1 Cancer immunotherapy predictive parameters |
| 04/10/2008 | WO2008022806A3 Methods for identifying therapeutical targets in tumors and for determining and targeting angiogenesis and hemostasis related to andenocarcinomas of the lung |